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Copyright © 2009 JCBN Summary We previously reported that the plasma level of endotoxin and colonic expression
of IgA in the mouse increased with obstructive jaundice induced by bile duct ligation (BDL).
To elucidate the mechanism of the BDL-induced increase, we analyzed the effect of BDL on
intestinal flora in wild type and inducible nitric oxide synthase (iNOS)-deficient mice
(iNOS−/−) using the terminal restriction fragment length polymorphism analysis (T-RFLP) and
16S rDNA clone libraries. The amounts of bacterial DNA detected in fecal samples from both
animal groups pretreated with antibiotics were extremely low as compared with untreated
groups. We found that the profiles of enteric bacteria changed markedly after BDL. The
bacterial composition is significantly different between not only wild type and iNOS−/− mice but
also those before and after BDL, respectively. Among enteric bacteria examined, Lactobacillus
murinus was found to increase markedly after BDL in rectum of both animal groups.
However, Escherichia coli markedly increased after BDL in the iNOS−/− mice. These findings
suggest that profiles of enteric flora change markedly in animals during obstructive jaundice
by some mechanism that is affected by bile constituents and iNOS-derived NO.
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Introduction
The composition of the intestinal microbial flora is rela-
tively stable and unique for each species and individual [1].
The commensal microbial flora in gastrointestinal tract plays
important roles in the maintenance and regulation of animal
health and nutrition, respectively. Under physiological
conditions, the presence of enteric microbiota is important
for the protection of animals against potential pathogens [2].
Hence, disruption of the ecological balance in intestinal
lumen gives rise to clinical complications [3, 4].
It has been suggested that bile acids are one of the impor-
tant factors that affect the ecological balance of intestinal
flora. In fact, the translocation of intestinal bacteria across
the mucosal layer increases markedly and sometimes causes
lethal endotoxemia in patients with obstructive jaundice
[5–8]. Changes in intestinal flora sometimes modulate the
population of lymphocytes that secrete Th2-type cytokines
and antibodies, such as IL-10 and IgA, respectively [9]. We
previously demonstrated that obstructive liver injury was
inhibited by pretreatment of animals with antibiotics [10].
Kinetic analysis revealed that disturbance of the ecological
balance of enteric bacteria played critical roles in the
regulation of immunological network among liver, spleen
and intestine, and in the pathogenesis of liver injury during
obstructive jaundice. However, the pathological significance
of the bile duct ligation (BDL)-induced changes in the
profiles of bacterial flora remains unknown. We also
reported that BDL increased endotoxin levels in plasma
more markedly with inducible nitric oxide synthase deficient
(iNOS−/−) mice than with wild-type animals and this increase
was strongly inhibited by antibiotics [10]. Since nitric oxide
(NO) has a potent antibacterial activity, bacterial composi-T-RFLP Analysis of Intestinal Bacterial Flora in BDL-mice
Vol. 44, No. 2, 2009
161
tion in the intestinal lumen would be affected by luminal
occurrence of NO. To examine the role of iNOS-derived NO
in the profiles of bacterial flora, we used iNOS−/− mice in this
study.
It has been practically difficult for a long time to charac-
terize the composition of intestinal microbiota predominantly
due to its large variations among individuals and a lack of
appropriate methods. For example, classic methods based on
cell culture are useful for the detection of less than 40% of
the microorganisms predominantly due to the difficulty to
handle anaerobic bacteria in the intestine [11]. However, the
recent development of molecular techniques for the analysis
of complex microbial communities bypassed the necessity
of cell culture and made considerable progress in the
characterization of intestinal bacteria [1,  3,  12,  13]. The
terminal restriction fragment length polymorphism analysis
(T-RFLP) is a useful method for the assessment of the
differences in the composition of intestinal microbial
communities [3, 14–16].
To elucidate the mechanism underling the pathological
changes induced by BDL, we analyzed the profiles of fecal
bacteria in C57BL and iNOS−/− mice before and after BDL
using TRFLP and 16S rDNA clone libraries.
Materials and Methods
Reagents
A Kit for the isolation of DNA from mouse feces and
primers 7F (5'-AGAGTTTGATCCTGGCTCAG-3') and
1492R (5'-GGTTACCTTGTTACGACTT-3') were obtained
from MO BIO laboratories Inc. (Carlsbad, CA) and SIGMA
Genosis (Japan), respectively. TaKaRa Ex TaqTM (1,000 U)
and TA Cloning® Kit and One Shot TOP 10 Chemically
Competent E. coli were obtained from Takara Bio (Shiga,
Japan) and InvitrogenTM (Carlsbad, CA), respectively.
Wizard Plus SV Minipreps DNA Purification System and
MontageTM PCR was obtained from Promega (Madison, WI)
and Millipore (Bedford, MA), respectively. Mouse mono-
clonal antibody against iNOS (610432), rabbit anti-iNOS
polyclonal antibody (KAS-NO001) were obtained from BD
Transduction Laboratories (San Jose, CA) and Stressgen
Biotechnologies (Victoria, Canada), respectively. Other
reagents used were of the highest grade commercially
available.
Animal experiments
Male C57BL/6J mice (20–25 g) and their iNOS−/− strain
were purchased from SLC (Shizuoka, Japan) and Jackson
Laboratories (Coldspring Harbor, MA), respectively. Animals
were allowed free access to laboratory chow (CE-2, Oriental
Yeast Co., Tokyo) and water ad libitum during the experi-
ments. All experiments were approved by the Institutional
Animal Care and Use Committee of Osaka City University
Medical School. Obstructive jaundice was elicited by the
common BDL as described previously [17]. Under light
ether anesthesia, animals were subjected to BDL. In the
control sham group, sham-operation was performed. At
indicated times after performing BDL, animals were
sacrificed to obtain blood and feces. The collected fecal
samples were stored at −80°C until analysis.
DNA extraction from fecal samples
Extraction and purification of DNA were carried out
according to the methods described by Clement and Kitts
[18] using an Ultra Clean Soil DNA isolation kit as
described previously [19].
PCR amplification for TRFLP analysis
A pair of universal primers, 27F and 1492R [20] was
used for PCR amplification and 27F was labeled with 6-
carboxyfluorescein (6-FAM). PCR was performed with a
Thermocycler T Gradient (Biometra, Göttingen, Germany)
in 50 µl of reaction mixture containing 5 µl of dissolved
DNA (100 ng), 1.25 U of TaKaRa Ex Taq, 10 × Ex Taq
buffer, 4 µl of dNTP mixture (2.5 mM each), and 10 pmol of
each primer. The amplification program used was as
follows: preheating at 95°C for 3 min; 30 cycles of
denaturation at 95°C for 30 s, annealing at 50°C for 30 s,
and extension at 72°C for 1.5 min; terminal extension at
72°C for 10 min [19, 21]. The amplified DNA was verified
by 1.5% agarose gel electrophoresis. PCR products were
purified using a MontageTM PCR (Millipore). The purified
PCR products were stored at −20°C until analysis.
TRFLP analysis
The restriction enzymes used were selected according to
the methods of Liu et al. [15] and Moyer et al. [22]. Purified
PCR products (4 µl) were digested with 20 U of either HhaI
or MspI (Takara Bio) in a total volume of 10 µl at 37°C
for 24 h. The lengths of the terminal restriction fragments
(T-RFs) were determined using a standard size marker
GS500 ROX and 1000 ROX (Applied Biosystems, Carlabad,
CA) in an ABI PRISMTM 3100 genetic analyzer (Applied
Biosystems) and GeneScan® Analysis Software (Applied
Biosystems). The peak of T-RFs was determined using
TRFLP analysis program (TAP) [23].
PCR amplification of 16S rDNA gene sequences and cloning
The samples used for cloning and sequencing were
obtained from mice before and 7 day after BDL. The 16S
rDNA gene was amplified using two universal primers 27F
and 1492R [19,  20]. PCR was performed as described
previously [24] and [19]. The amplified 16S rDNA genes
were purified using an Ultra Clean PCR Clean-up Kit (Mo
Bio Laboratories). The purified amplicons were cloned into
pCR® 2.1 vectors (Invitrogen, San Diego, CA), and OneJ.-Y. Hong et al.
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Shot® INVaF’ competent cells were transformed [19]. The
transformants were randomly picked and purified with
Wizard® Plus SV Minipreps DAN Purification System
(Promega).
DNA sequencing and phylogenetic analysis
Cycle sequencing was performed with a Big Dye®
Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems),
27F or 1492R primers, and ABI PRISMTM 3100 Genetic
Analyzer (Applied Biosystems). All sequences were
compared with similar sequences of the reference organisms
by using BLAST search [25].
Histological analysis
The colon specimens were rapidly frozen in an OCT
embedding medium (Tissue-Tek, Elkhart, IN) and stored at
−80°C until use. Cryostat sections (6 µm thickness) were
fixed in ice-cold acetone for 10 min. The expression of
iNOS was evaluated immunohistochemically under a fluo-
rescent microscope as described previously [26, 27]. Rabbit
anti-iNOS polyclonal antibody (KAS-NO001) was obtained
from Stressgen Biotechnologies (Victoria, Canada).
Western blot analysis
The colon was rinsed with saline and homogenized in a
lysis buffer containing 0.5% Nonidet P-40, 10% glycerol,
137 mM NaCl, 2 mM ethylendiamine-tetraacetic acid, and
50 mM Tris-HCl buffer (pH 8.0). After centrifugation at
3,000 × g for 10 min, the supernatant was separated and
stored at −80°C. The stored specimens were subjected to
7.5% polyacrylamide gel electrophoresis (PAGE) in the
presence of 0.1% SDS. The electrophoresed proteins in the
gel were transferred to an Immobilon membrane (Millipore).
The membrane was blocked with 5% skim milk at 4°C for
overnight, subsequently incubated with primary antibodies
at 25°C for 1 h and then with horseradish peroxidase-
conjugated secondary antibodies. Immune complexes thus
formed were detected with ECL reagents (Amersham
Bioscience, Buckinghamshire, UK).
Results
Analysis of fecal bacterial community by TRFLP
Although bacterial DNA was easily detected in fecal
samples from wild and iNOS−/− mice, it was practically
difficult to detect DNA from both animal groups pretreated
with antibiotics (Fig. 1). TRFLP patterns of the wild and
iNOS−/− mice were compared using two different restriction
enzymes before and after BDL (Fig. 2 and 3). The profiles of
bacterial community in the feces from wild and iNOS−/−
mice changed markedly after BDL. The profiles of bacterial
distribution in the feces from the rectum and the cecum also
differed significantly after BDL. After digestion with HhaI,
terminal restriction fragments (T-RFs) at bp 249 and 370,
and bp 370 were detected in the feces from rectum and
cecum of wild type mice after BDL. In contrast, HhaI
digestion revealed T-RFs at bp 233, 249, and 370, and bp
197 and 208 in the feces from the rectum and cecum of
iNOS−/− mice that had been subjected to BDL (Fig. 2). MspI
digestion revealed T-RFs at bp 491, 492 and 565, and bp 491
in the feces from the rectum and cecum of BDL-treated wild
type mice. MspI digestion revealed T-RFs at bp 492, 568
and 583, and bp 223 and 269 in the fecal sample from the
rectum and cecum of BDL-treated iNOS−/− mice (Fig. 3).
BDL induced expression of iNOS in the colon
Colonic expression of iNOS markedly increased after
BDL. As shown in Fig. 4 and 5, the expression of iNOS in
the wild type mice increased after BDL, peaked on day 3,
and decreased thereafter. Naturally, no iNOS was induced
by BDL in the knockout mice.
Identification of bacterial 16S rDNA gene
The sequences of 16S rDNA clones were used to identify
enteric bacterial profiles in the feces from the wild type and
iNOS−/− mice before and after BDL (Table 1). Among fifty
clones from the inoculum analyzed, no exact 16S rDNA
gene similarity limits exist to define specific taxa, such as
genus and species. The definition of species generaly
requires sequence similarities of greater than 98% [28]. The
Fig. 1. Bacterial DNA extraction from fecal samples. DNA was
extracted from 50 mg of the fecal sample. A pair of
universal primers, 27F (5'-AGAGTTTGATCCTGGCT-
CAG-3') and 1492R (5'-GGTTACCTTGTTACGACTT-
3'), were used for PCR amplification. The amplified
DNA was verified by 1.5% agarose gel electrophoresis.T-RFLP Analysis of Intestinal Bacterial Flora in BDL-mice
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Fig. 2. T-RFLP analysis of intestinal microbiota before and after BDL. Data shows T-RFLP patterns of 16S rDNA from mouse feces
(day 0~7) digested with HhaI. 16S rDNA were amplified using universal primers 27F and 1492R. The minimum and maximum
values of the ordinate of each T-RFLP pattern are 0 to 800 fluorescence intensity (arbitary units) for HhaI. Fecal samples from
the rectum of (A) wild and (B) iNOS−/− mice, and the cerum of (C) wild and (D) iNOS−/− mice
Fig. 3. T-RFLP analysis of intestinal microbiota before and after BDL. Data shows T-RFLP patterns of 16S rDNA from mouse feces
(day 0~7) digested with MspI. Other conditions were same as in Fig. 2.J.-Y. Hong et al.
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compositions of enteric bacteria from wild type mice
differed significantly from that of iNOS−/− mice; both of
them changed markedly after BDL. Among various bacteria
observed,  Lactobacillus murinus in the rectum markedly
increased after BDL both in wild type and iNOS−/− mice. On
day 7 after BDL, total numbers of Lactobacillus murinus in
the rectum were found to be about 35.0% and 30.2% of
the flora in wild type and iNOS−/− mice, respectively.
Bacteroides acidofaciens in the rectum of wild animals
showed no detectable changes even after BDL. In contrast,
Escherichia coli in the rectum of iNOS−/− mice markedly
increased after BDL (Table 1). On day 7 after BDL,
Bacteroides intestinalis, Clone aab24h05, and Bacteroides
acidofaciens in the cecum of wild animals increased to 30%,
12%, and 10% of the total number of enteric bacteria,
respectively (Table 1).
Discussion
The present work shows that bacterial composition in
the intestinal lumen was different in wild type and iNOS−/−
mice, and both of them changed markedly after BDL. Bile
acids have been known to inhibit bacterial overgrowth and
their translocation across the intestinal mucosa [5, 6, 29].
Since NO has a potent antibacterial activity, bacterial
composition in the intestinal lumen would be affected by
luminal occurrence of NO.
The population of E. coli in the intestine increased after
BDL in iNOS−/− mice but not in wild type mice. Although,
the lifetime of NO has been postulated to be extremely short
(several seconds) particularly under air atmospheric condi-
tions, it is fairly stable under low oxygen tensions [30–32].
It should be noted that oxygen is the substrate for NOS
and, hence, the rate of NO synthesis may decrease under
physiological low oxygen tensions in the intestinal lumen.
Thus, the enhancement of NO action by low oxygen tensions
may occur minimally in anaerobic compartments, such as in
the large intestinal lumen. In this context, the Km value of
iNOS for molecular oxygen has been reported to be about
6.3 ± 0.9 µM [33]. Therefore, macrophages and neutrophils
not only in the circulation but also in the intestinal mucosa
might generate reactive oxygen species including NO [34,
35]. Because of a gaseous nature of NO, it easily diffuses
from a mucosal site of generation into intestinal lumen.
Thus, NO generated by the activated leukocytes in an
inflammatory lesion of the intestine might reach to its
lumenal space where a large number of enteric bacteria
live. We previously reported that endotoxin levels in mouse
plasma increased after BDL; its increase was more marked
in iNOS−/− than in the wild mice [10]. The increased endo-
toxin in BDL-treated iNOS−/− mice might reflect the change
Fig. 4. Histological examination of the expression of iNOS in the colon. At the indicated times after BDL, colon specimens were
frozen, cut into thin sections, treated with anti-iNOS antibody and then stained with FITC-conjugated second antibody. Scale
bar = 50 µm
Fig. 5. Western blotting analysis of expression of iNOS in the
colon. At the indicated times after BDL, colon specimens
were collected. Each amounts of protein (30 µg/lane)
from colon was subjected to a 7.5% SDS-PAGE, and
the electrophoresed proiteins were transferred onto
Immobilon-P membranes, and analyzed using anti-iNOS
antibody. The bands with 130 kDa responsible for iNOS
were seen in colon specimens from BDL mice. Data show
one typical result out of 3 representative experiments.T-RFLP Analysis of Intestinal Bacterial Flora in BDL-mice
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in intestinal flora, such as increased E. coli.
Interestingly, Lactobacillus murinus markedly increased
after BDL both in wild type and iNOS−/− mice. Since the
growth of Lactobacilli and Bifidobacteria were inhibited by
bile acids [36], it is not surprising that L. murinus increased
markedly after BDL. Lactobacilli are a major component of
the commensal microbial flora in the intestine both of
humans and animals [37]. Such probiotic bacteria have
been shown to give beneficial effects including improve-
ment of intestinal health, enhancement of the immunological
activity, synthesis of nutrients and reduction of lactose
intolerance, allergic reactions, and risk of cancers [37–39].
Although the mechanisms by which such probiotics exert
their beneficial effects are largely unknown, it may involve
regulation of lumenal pH, and competition for available
nutrients and growth factors with pathogens. We previously
reported that obstructive liver injury was inhibited by the
administration of antibiotics and that enteric bacteria play
critical roles in the pathogenesis of liver injury induced by
obstructive jaundice [10]. However, the role of L. murinus
in the pathological events in the intestine of BDL-treated
animals remains obscure.
It should be noted that large numbers of unknown bacteria
not cultured successfully are living in the intestine and play
a role in the modulation of intestinal diseases. Thus, TRFLP
is a useful method for the assessment of the changes in
intestinal microbial flora under physiological as well as
pathological conditions.
The present work suggests that bacterial composition in
the intestinal lumen changes significantly after BDL by a
mechanism that is affected by iNOS-derived NO.
Recent studies revealed that metagenome analysis is
also an efficient and convenient method for the analysis of
enteric bacteria. Pathophysiological significance of BDL-
induced changes in intestinal flora should be studied further
using more convenient methods.
Table 1. Identification by 16S rDNA sequences analysis
Values show the percentage of bacterial species obtained from the rectum and cecum of wild and iNOS−/− mice.
Wild (%) iNOS−/− (%)
rectum
Day 0
Clone Adhufec 33 ml 10.4 Clone R-1264 (2) 16.7
Uncultured rumen bacterium gene 5.1 Clone aab23g09 11.1
Bacteroides acidofaciens 5.1 Clone F3 11.1
Clone R-1264(2) 5.1 Clone aab21h12 8.3
Clone ratBN020109C 5.1 Clone M1-g02-3 8.3
The others (each less than 4%) 69.2 Clone aab42c05 5.1
Lactobacillus johnsonii NCC 533 5.1
The others (each less than 4%) 33.3
Day 7
Lactobacillus murinus 35.0 Lactobacillus murinus 30.2
Clone aab24h05 7.5 Escherichia coli 25.6
Clone M3-c08-3 5.0 Shigella boydii strain 5216-70 7.0
Bacteroides acidofaciens 5.0 The others (each less than 4%) 37.2
The others (each less than 4%) 47.5
cecum
Day 0
Clone aab22a11 7.3 Clone M2-a05 11.4
Lactobacillus johnsonii NCC 533 7.3 Clone aab23f05 8.6
Bacteroides acidofaciens 4.9 Mucispirillum schaedleri strain HRI I 17 5.7
Clone M1-b06-1 4.9 The others (each less than 4%) 74.3
Clone aab21h12 4.9
The others (each less than 4%) 70.7
Day 7
Bacteroides intestinalis 30.0 Clone 28-2 small subunit 12.9
Clone aab24h05 12.0 Clone aab 24a06 6.5
Bacteroides acidofaciens 10.0 The others (each less than 4%) 80.6
Uncultured Gram-positive bacterium 6.0
Lactobacillus murinus 4.0
Escherichia coli 4.0
Clone abc 38b10.x1 4.0
The others (each less than 4%) 30.0J.-Y. Hong et al.
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